We also identified the antimalarial artesunate (ART) induces the degradation of BCR-ABL and CML cell death via inhibiting the interaction between USP7 and BCR-ABL. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.